Profile picture of Quartz
The most underpriced stocks right now: Wall Street seems bored by these big household names
qz.com/most-underpriced-stocks-chevron-goldman-sachs-verizon-1851357002
The most underpriced stocks right now
Profile picture of Bloomberg
Ex-Goldman Partner’s Hedge Fund Vinland Plans New York Office: Vinland Capital, a Brazilian hedge fund founded by former Goldman Sachs Group Inc ...
bloomberg.com/news/articles/2024-03-04/former-goldman-sachs-partner-s-hedge-fund-plans-new-york-office
Ex-Goldman Partner’s Hedge Fund Vinland Plans New York Office
Profile picture of Business Insider
Ozempic could grow US economy, says Goldman Sachs: The US economy could see a growth spurt if more people use so-called weight loss injections like Ozempic to ...
businessinsider.de/wirtschaft/international-business/ozempic-abnehmspritze-koennte-us-wirtschaft-wachsen-lassen-so-goldman-sachs/
Ozempic could grow US economy, says Goldman Sachs
Profile picture of Reuters
Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says: The widespread use of powerful new weight-loss drugs in the United States could boost ...
reuters.com/business/healthcare-pharmaceuticals/weight-loss-drugs-could-boost-us-gdp-by-1-coming-years-goldman-says-2024-02-22/
Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says
Profile picture of DER AKTIONÄR
BioNTech under pressure: Now the price targets are also falling: BioNTech shares fall after disappointing annual figures; Goldman Sachs and Jefferies cut price ...
deraktionaer.de/artikel/pharma-biotech/biontech-unter-druck-jetzt-fallen-auch-die-kursziele-20353493.html
BioNTech under pressure: Now the price targets are also falling
Quick Glance: BioNTech Focuses on Cancer Drug Development after Revenue Plunge
  • BioNTech reported a significant drop in revenue and earnings in 2023 as it shifts focus towards cancer drug development.

  • The company aims for revenues between 2.5 billion to 3.1 billion euros in 2024.

  • BioNTech plans to launch its first oncology drug in 2026 and secure ten indication approvals by 2030.

  • Partner Pfizer anticipates a decline in sales for the COVID-19 vaccine, while BioNTech invests in scaling up its oncology business.
Profile picture of BÖRSE ONLINE
Profile picture of Reuters
Goldman raises global equities to 'overweight' on economic growth prospects: Goldman Sachs upgraded its rating on global equities to "overweight" on prospects of ...
reuters.com/markets/goldman-raises-global-equities-overweight-economic-growth-prospects-2024-02-19/
Goldman raises global equities to 'overweight' on economic growth ...
Profile picture of CNBC
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
cnbc.com/2024/02/26/granolas-stocks-power-europe-to-record-highs-drawing-magnificent-7-comparisons.html
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent ...
Profile picture of CNBC
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
cnbc.com/2024/03/01/europe-is-having-its-worst-earnings-season-since-the-onset-of-covid.html
Europe is having its worst earnings season since the onset of Covid — with ...
Profile picture of MarketWatch
This basket of global stocks from Goldman Sachs has nearly kept pace with the Magnificent Seven while excluding tech
marketwatch.com/story/this-basket-of-global-stocks-from-goldman-sachs-has-nearly-kept-pace-with-the-magnificent-seven-while-excluding-tech-03fcfd6a
This basket of global stocks from Goldman Sachs has nearly kept pace with ...
Profile picture of WION
The UK was one of the worst-hit major economies during the cost of living crisis post-pandemic. Since then, the economy has shown signs of recovery ... Show more
Profile picture of Barron's
The Stock Market Doesn’t Care About the Slow Start to Earnings Season: Earnings beats haven’t been rewarded, but the stock market rose to a new high anyway.
barrons.com/articles/the-stock-market-doesnt-care-about-the-slow-start-to-earnings-season-dd38e4c7
The Stock Market Doesn’t Care About the Slow Start to Earnings Season
Profile picture of Insider (news website)
Economy Outlook: Why Red Sea disruptions won't fuel US inflation spike: The jump in freight costs hasn't coincided with factory shutdowns like during the ...
businessinsider.com/economy-outlook-goldman-sachs-red-sea-shipping-inflation-federal-reserve-2024-1
Economy Outlook: Why Red Sea disruptions won't fuel US inflation spike
Profile picture of Axios (website)
The return-to-office wars are over — here's who won: The losers: CEOs who wanted butts in seats 5 days a week.
axios.com/2024/01/16/ceo-return-to-office-wars
The return-to-office wars are over — here's who won
Profile picture of Insider (news website)
Goldman Sachs: 3 threats to a strong labor market: The labor market may be returning to pre-pandemic conditions, Goldman Sachs found, though hiring rates are ...
businessinsider.com/labor-market-job-openings-unemployment-rate-goldman-sachs-economic-outlook-2024-1
Goldman Sachs: 3 threats to a strong labor market
Profile picture of The Straits Times
Drowning in work, but whose fault is that?: Goldman is well known for having a hard-driving culture.
straitstimes.com/opinion/drowning-in-work-but-whose-fault-is-that
Drowning in work, but whose fault is that?
Profile picture of Bloomberg
An ex-Goldman boss sued the bank for more than £1 million in London after alleging a “chaotic” working environment pushed him into a mental and physical health ... Show more
Profile picture of Asia Times
China is not dead yet: China is not dead yet Uwe Parpart discusses the idea that great powers tend to become more aggressive when they fear a decline in their ...
asiatimes.com/2024/02/china-is-not-dead-yet/
China is not dead yet
Profile picture of Frankfurter Allgemeine Zeitung
Automation of Jobs: When AI Takes Over: Now it's also affecting academics: They're afraid of becoming superfluous through automation ...
faz.net/aktuell/karriere-hochschule/buero-co/automatisierung-von-berufen-wenn-die-ki-uebernimmt-19458695.html
Automation of Jobs: When AI Takes Over
Profile picture of Handelsblatt
Profile picture of The Irish Times
Eight myths about fitness we tend to fall for: Fitness culture is rife with misconceptions and tips based on ‘anecdote and gym lore’
irishtimes.com/health/your-fitness/2024/01/23/eight-myths-about-fitness-we-tend-to-fall-for/
Eight myths about fitness we tend to fall for
Profile picture of Insider (news website)
Stock market outlook: Obesity drugs, AI in Goldman Sachs' top themes: The strategists named the stocks that may be poised to rally in the new year as broader ...
markets.businessinsider.com/news/stocks/investing-outlook-markets-obesity-drugs-ai-manufacturing-green-recession-economy-2024-1
Stock market outlook: Obesity drugs, AI in Goldman Sachs' top themes
Profile picture of finanzen.net
Profile picture of DER AKTIONÄR
DAX expected to be weaker again: DocMorris, Morgan Stanley, Goldman Sachs, Allianz, Munich Re, Lanxess, Hugo Boss and Lanxess in focus - this is important ...
deraktionaer.de/artikel/indizes/dax-erneut-schwaecher-erwartet-docmorris-morgan-stanley-goldman-sachs-allianz-munich-re-lanxess-hugo-boss-und-lanxess-im-fokus-das-ist-heute-wichtig-20347751.html
DAX expected to be weaker again: DocMorris, Morgan Stanley, Goldman Sachs ...
Profile picture of Business Insider
Goldman Sachs: This stock can rise 140 percent by 2028: If more weight loss drugs are approved, this pharmaceutical company's stock could skyrocket in the next ...
businessinsider.de/wirtschaft/international-business/goldman-sachs-diese-aktie-kann-bis-2028-um-140-prozent-steigen/
Goldman Sachs: This stock can rise 140 percent by 2028
Profile picture of Insider (news website)
Eli Lilly stock outlook has 140% upside amid GLP-1 drug growth: Goldman: "GLP-1 based medicines will have a profound effect on the health of individuals ...
markets.businessinsider.com/news/stocks/eli-lilly-stock-price-outlook-glp1-weight-loss-drug-growth-2023-12
Eli Lilly stock outlook has 140% upside amid GLP-1 drug growth: Goldman
Profile picture of Business Insider
Goldman Sachs: 7 most important topics on the stock market this year: AI, industry and anti-obesity drugs. These are the seven most important topics on the stock ...
businessinsider.de/wirtschaft/goldman-sachs-sieben-wichtigste-themen-an-der-boerse-in-2024/
Goldman Sachs: 7 most important topics on the stock market this year
Profile picture of BÖRSE ONLINE
Profile picture of BÖRSE ONLINE
New highs soon for Allianz, Volkswagen and BASF shares? This is what Goldman Sachs and JP Morgan are now saying
boerse-online.de/nachrichten/aktien/bald-neue-hoechststaende-bei-aktien-von-allianz-volkswagen-und-basf-das-sagen-jetzt-goldman-sachs-und-jp-morgan-20346480.html
New highs soon for Allianz, Volkswagen and BASF shares? This is what ...
Profile picture of DER AKTIONÄR
Morphosys: Strong start to the week - Analysts in conflict: Morphosys shares gain 26.8% after positive study results for its product Pelabresib for the treatment ...
deraktionaer.de/artikel/pharma-biotech/morphosys-starker-wochenstart-analysten-im-zwiespalt-20345509.html
Morphosys: Strong start to the week - Analysts in conflict
Profile picture of CNBC
Goldman Sachs thinks that only an unforeseen shock is likely to cause a recession in 2024
cnbc.com/2023/11/16/goldman-sachs-thinks-that-only-an-unforeseen-shock-is-likely-to-cause-a-recession-in-2024.html
Goldman Sachs thinks that only an unforeseen shock is likely to cause a ...
Profile picture of Bloomberg
Goldman Says Sharp Drop in Volatility Is Opportunity for Hedging: The recent sharp pullback in volatility as year-end approaches creates hedging opportunities ...
bloomberg.com/news/articles/2023-11-28/goldman-says-sharp-drop-in-volatility-is-opportunity-for-hedging
Goldman Says Sharp Drop in Volatility Is Opportunity for Hedging
Profile picture of Bloomberg
Saudi Arabia Goes Into Bat With Its Latest Sports Bid: Hi, it’s Giles Turner in London with the latest on Saudi Arabia’s global sporting ambitions. Elsewhere ...
bloomberg.com/news/newsletters/2023-11-03/saudi-arabia-goes-into-bat-with-its-latest-sports-bid
Saudi Arabia Goes Into Bat With Its Latest Sports Bid
Profile picture of Bloomberg
Goldman Earmarks Extra $690 Million for Pay in Bid to Stem Angst: A year ago, Goldman Sachs Group Inc. wanted to make its staff share in the pain of slumping ...
bloomberg.com/news/articles/2023-10-17/goldman-earmarks-extra-690-million-for-pay-in-bid-to-stem-angst
Goldman Earmarks Extra $690 Million for Pay in Bid to Stem Angst
Profile picture of CNBC
Time to buy Siemens and HelloFresh after big share price moves? Here's what analysts say
cnbc.com/2023/11/17/hfg-and-sie-stock-time-to-buy-siemens-hellofresh-shares-what-analysts-say.html
Time to buy Siemens and HelloFresh after big share price moves? Here's ...
Profile picture of CNBC
Profile picture of Free Malaysia Today
Companies are taking action to protect employees' mental health: From Google and Microsoft to Goldman Sachs, many major firms now offer support to staff ...
freemalaysiatoday.com/category/leisure/2023/10/24/companies-are-taking-action-to-protect-employees-mental-health/
Companies are taking action to protect employees' mental health
Profile picture of National Post
Workers to spend at least 20% less time in the office than before pandemic: Workers will likely spend 20% to 25% less time in the office than before the pandemic ...
financialpost.com/fp-work/workers-spent-20-percent-less-time-office
Workers to spend at least 20% less time in the office than before pandemic
Profile picture of DER AKTIONÄR
BioNTech by the numbers - this is how it continues now: BioNTech reports profit in Q3 despite shrinking Covid-19 vaccine sales, thanks to partnerships such as ...
deraktionaer.de/artikel/pharma-biotech/biontech-nach-den-zahlen-so-geht-es-jetzt-weiter-20343137.html
BioNTech by the numbers - this is how it continues now
Profile picture of Bloomberg
You Can’t Sell Trees No One Cuts Down: Also the CEO of Goldman Sachs is no longer a DJ, Ozempic, drug cartels and meal allowances.
bloomberg.com/opinion/articles/2023-10-17/you-can-t-sell-trees-no-one-cuts-down
You Can’t Sell Trees No One Cuts Down
Profile picture of CNBC
Earnings playbook: Netflix and Goldman Sachs headline a big week of reports: Expectations for the overall earnings season are muted.
cnbc.com/2023/10/15/earnings-playbook-netflix-and-goldman-sachs-headline-a-big-week-of-reports.html
Earnings playbook: Netflix and Goldman Sachs headline a big week of ...
Profile picture of Bloomberg
JPMorgan Breaks With Goldman on India Stocks View Before Polls: JPMorgan Chase & Co. strategists upgraded Indian stocks to overweight on optimism that higher ...
bloomberg.com/news/articles/2023-10-27/jpmorgan-breaks-with-goldman-on-india-stocks-view-before-polls
JPMorgan Breaks With Goldman on India Stocks View Before Polls
Profile picture of BÖRSE ONLINE
Acute uncertainty at the DAX - Airbus and Brenntag in focus: Goldman Sachs and Bank of America report their figures today. DAX remains flat while Airbus shares ...
boerse-online.de/nachrichten/rohstoffe/boerse-so-geht-es-fuer-den-dax-nach-einem-erfolgreichen-montag-weiter-aktien-von-adler-und-airbus-im-fokus-20341274.html
Acute uncertainty at the DAX - Airbus and Brenntag in focus
Profile picture of DER AKTIONÄR
Opening Bell: Gold, Walmart, Amazon, Bank of America, Johnson & Johnson, Goldman, Apple, Lululemon
12:28
Profile picture of Bloomberg
How 2 Ex-Goldman Bankers Built a $1 Billion Coal Business: A commodities newcomer is using deep connections with US miners to compete with industry giants — and ...
bloomberg.com/news/articles/2023-09-20/how-2-ex-goldman-bankers-built-a-1-billion-coal-business
How 2 Ex-Goldman Bankers Built a $1 Billion Coal Business
Profile picture of DER AKTIONÄR
DAX hardly changed: Middle East conflict, Bank of America, Goldman Sachs, Rio Tinto, Drägerwerk, Pfizer, BioNTech and Airbus in focus - this is important today
deraktionaer.de/artikel/indizes/dax-kaum-veraendert-nahost-konflikt-bank-of-america-goldman-sachs-rio-tinto-draegerwerk-pfizer-biontech-und-airbus-im-fokus-das-ist-heute-wichtig-20341258.html
DAX hardly changed: Middle East conflict, Bank of America, Goldman Sachs ...
Profile picture of Reuters
Dutch watchdog says Goldman had short position in Philips: The Dutch financial markets watchdog said on Monday an investigation had revealed that Goldman Sachs ...
reuters.com/markets/europe/goldman-sachs-discloses-short-position-philips-after-dutch-regulator-review-2023-09-11/
Dutch watchdog says Goldman had short position in Philips
Quick Glance: Goldman Sachs reveals short position in Philips after review by Dutch regulator
  • Dutch financial markets watchdog updates filings to reflect Goldman Sachs' large gross short position in Philips.

  • Goldman Sachs, acting on behalf of Exor, could not be reached for comment.

  • The review has led to additional disclosures of gross short positions by Goldman Sachs in the AFM register.

  • Philips has no additional comment.
Profile picture of The Star (Malaysia)
Home Minister Datuk Seri Saifuddin Nasution Ismail on Monday (Oct 9) said the police will determine if it will proceed with the existing probe or initiate a ... Show more
Profile picture of Bloomberg
Student Loan Payments With Interest: Borrowers Pay Down Debt Before Restart: Payments to the Department of Education surged to pre-pandemic levels in August ...
bloomberg.com/news/articles/2023-09-05/student-loan-payments-with-interest-borrowers-pay-down-debt-before-restart
Student Loan Payments With Interest: Borrowers Pay Down Debt Before ...
Quick Glance: Important Information: Student Loan Repayments Resuming
  • Federal student loans will begin accruing interest again on Sept. 1 after a three and a half year pause.

  • Pausing student loan repayments had a major impact on borrowers' financial stability, raising concerns about resuming monthly repayments.

  • Betsy Mayotte, president and founder of the Institute of Student Loan Advisors, warns that borrowers may struggle to fit the payment back into their budgets for various reasons.

  • For some, pursuing a loan forgiveness program is the best way to minimize long-term costs. For most others, aggressively paying off loans is key to reducing total interest.
Profile picture of South China Morning Post
Bankers from Goldman Sachs and Morgan Stanley will be among about 300 industry heavyweights from around the world who will join the HKMA next month for a ... Show more
Profile picture of Insider (news website)
Obesity's economic cost is expected to soar to $4 trillion by 2035: "By fighting obesity, these drugs seem to be fighting heart disease, which is the leading ...
businessinsider.com/obesity-economic-cost-4-trillion-wegovy-ozempic-weight-loss-drugs-2023-9
Obesity's economic cost is expected to soar to $4 trillion by 2035
Profile picture of CNBC
Goldman Sachs says this blood cancer treatment stock can gain 70% ahead of planned drug launch
cnbc.com/2023/09/12/goldman-sachs-says-this-blood-cancer-treatment-stock-can-gain-70percent.html
Goldman Sachs says this blood cancer treatment stock can gain 70% ahead of ...
Profile picture of Essence
Goldman Sachs Gives $5M To ‘On The Road Lending,’ A Non-Profit That Helps Black Women Secure Low Interest Car Loans
essence.com/news/money-career/goldman-sachs-on-the-road-lending/
Goldman Sachs Gives $5M To ‘On The Road Lending,’ A Non-Profit That Helps ...
Profile picture of DER AKTIONÄR
DAX fails at 16,000 points - BASF increases - Porsche jump into plus - Goldman Sachs switches sides at Morphosys - Hornbach buckles
deraktionaer.de/artikel/maerkte-forex-zinsen/dax-scheitert-bei-16000-punkten-basf-legt-zu-porsche-springen-in-plus-goldman-sachs-wechselt-bei-morphosys-die-seite-hornbach-knickt-ein-20339540.html
DAX fails at 16,000 points - BASF increases - Porsche jump into plus - ...
Profile picture of DER AKTIONÄR
Morphosys with price jump: Goldman Sachs increases price target by 168 percent: Morphosys shares rise 7.6% after upgrade by Goldman Sachs.
deraktionaer.de/artikel/pharma-biotech/morphosys-mit-kurssprung-goldman-sachs-erhoeht-kursziel-um-168-prozent-20339485.html
Morphosys with price jump: Goldman Sachs increases price target by 168 ...
Profile picture of Insider (news website)
Sasha Kelemen at Leerink is funding women's healthcare: At 35 years old, Sasha Kelemen runs what she says is the only women's-health-focused investment-banking ...
businessinsider.com/sasha-kelemen-leerink-partners-funding-womens-health-2023-8
Sasha Kelemen at Leerink is funding women's healthcare
Profile picture of Fox Business
Home prices will rise in 2023 as affordability crisis worsens, Goldman says: Goldman Sachs strategists said in an analyst note this week that they no longer ...
foxbusiness.com/economy/home-prices-will-rise-2023-affordability-crisis-worsens-goldman-says
Home prices will rise in 2023 as affordability crisis worsens ...
Profile picture of The New Zealand Herald
Goldman Sachs researchers estimate China’s total property debt was 48 per cent of GDP at the end of last year, worth US$8.4 trillion ... Show more
Profile picture of Insider (news website)
Transgender Goldman Sachs executive on what she learned coming out in the workplace
businessinsider.com/transgender-goldman-sachs-executive-lessons-coming-out-workplace-2023-8
Transgender Goldman Sachs executive on what she learned coming out in the ...
Profile picture of Bloomberg
Banks Get Tough on Return-to-Office Laggards After Summer Break: More than three years from the onset of the coronavirus pandemic, Wall Street is still working ...
bloomberg.com/news/articles/2023-09-01/banks-get-tough-on-return-to-office-laggards-after-summer-break
Banks Get Tough on Return-to-Office Laggards After Summer Break
Profile picture of CNBC
Why the U.S. has a productivity problem: Labor productivity is a key economic indicator policymakers use to gauge the health of the economy. But U.S ...
cnbc.com/2023/08/25/why-the-us-has-a-productivity-problem.html
Why the U.S. has a productivity problem
Profile picture of thedailybeast.com
Goldman Sachs Analyst John Castic May Have Died From Peanut Allergy: Dad : John Castic was the second man who turned up dead in a creek after going missing ...
thedailybeast.com/goldman-sachs-analyst-john-castic-may-have-died-from-peanut-allergy-dad
Goldman Sachs Analyst John Castic May Have Died From Peanut Allergy: Dad
Profile picture of Bloomberg
Goldman Takes $1 Billion Hit From Real Estate Investments: It’s a tough time to be in the real estate business. That means Goldman Sachs Group Inc ...
bloomberg.com/news/articles/2023-07-19/real-estate-woes-drive-billion-dollar-hit-for-goldman-sachs
Goldman Takes $1 Billion Hit From Real Estate Investments
Profile picture of DER AKTIONÄR
Amazon: Increasingly Profitable: Goldman Sachs analysts see Amazon clearly on course to return to pre-Corona profitability.
deraktionaer.de/artikel/aktien/amazon-immer-profitabler-20337793.html
Amazon: Increasingly Profitable
Profile picture of The Star (Malaysia)
AI anxiety: workers fret over uncertain future: The tidal wave of artificial intelligence (AI) barrelling toward many professions has generated deep anxiety ...
thestar.com.my/tech/tech-news/2023/08/04/ai-anxiety-workers-fret-over-uncertain-future
AI anxiety: workers fret over uncertain future
Quick Glance: Amazon's Focus on Generative AI Across All Divisions
  • Like other major tech companies, Amazon is heavily focused on generative artificial intelligence.

  • CEO Andy Jassy confirmed that every division at Amazon is working on multiple generative AI projects.

  • Jassy emphasized that every team at Amazon is building generative AI applications to reinvent and enhance the customer experience.

  • Amazon plans to incorporate generative AI in all its consumer-facing products and services, highlighting its significance and investment.
Profile picture of Insider (news website)
Get ready for historic slowdown in home-price growth: Goldman Sachs: House prices are poised to rise by less than 2% this year and in 2024, and by less than 4% ...
markets.businessinsider.com/news/stocks/housing-market-outlook-home-prices-goldman-fed-interest-mortgage-rates-2023-7
Get ready for historic slowdown in home-price growth: Goldman Sachs
Profile picture of Bloomberg
Goldman Said to Cut Oncoclinicas Stake in $187 Million Offering: Oncoclinicas do Brasil Servicos Medicos SA, a cancer-care provider owned by Goldman Sachs Group ...
bloomberg.com/news/articles/2023-06-20/goldman-said-to-cut-oncoclinicas-stake-in-187-million-offering
Goldman Said to Cut Oncoclinicas Stake in $187 Million Offering